期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 275, 期 9, 页码 6267-6275出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.275.9.6267
关键词
-
资金
- NCI NIH HHS [CA 42564, CA 78230] Funding Source: Medline
The retroviral oncogene p3k (v-p3k) of avian sarcoma virus 16 (ASV16) codes for the catalytic subunit of phosphoinositide (PI) 3-kinase, p110 alpha. The v-P3k protein is oncogenic in vivo and in vitro; its cellular counterpart, c-P3k, lacks oncogenicity, Fusion of viral Gag sequences to the amino terminus of c-P3k activates the transforming potential, Activation can also be achieved by the addition of a myristylation signal to the amino terminus or of a farnesylation signal to the carboxyl terminus of c-P3k, A mutated myristylation signal was equally effective; it also caused a strong increase in the kinase activity of P3k, Mutations that inactivate lipid kinase activity abolish oncogenicity, The transforming activity of P3k is correlated with the ability to induce activating phosphorylation in Akt. Point mutations and amino-terminal deletions recorded in v-P3k were shown to be irrelevant to the activation of oncogenic potential, Interactions of P3k with the regulatory subunit of PI 3-kinase, p85, or with Pas are not required for transformation, These results support the conclusion that the oncogenicity of P3k depends on constitutive lipid kinase activity. Akt is an important and probably essential downstream component of the oncogenic signal from P3k.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据